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Abstract
Legumes and the polyphenolic compounds present in them have gained a lot of interest due to their beneficial health
implications. Dietary polyphenolic compounds, especially flavonoids, exert antioxidant properties and are potent inhibitors
of xanthine oxidase (XO) activity. XO is the main contributor of free radicals during exercise but it is also involved in
pathogenesis of several diseases such as vascular disorders, cancer and gout. In order to discover new natural, dietary XO
inhibitors, some polyphenolic fractions and pure compounds isolated from two legume plant extracts were tested for their
effects on XO activity. The fractions isolated from both Vicia faba and Lotus edulis plant extracts were potent inhibitors of XO
with IC50 values range from 40–135 mg/mL and 55–260 mg/mL, respectively. All the pure polyphenolic compounds inhibited
XO and their Ki values ranged from 13–767 mM. Ten of the compounds followed the non competitive inhibitory model
whereas one of them was a competitive inhibitor. These findings indicate that flavonoid isolates from legume plant extracts
are novel, natural XO inhibitors. Their mode of action is under investigation in order to examine their potential in drug
design for diseases related to overwhelming XO action.
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Introduction
Xanthine oxidase (XO) is a flavoprotein, which belongs to
molybdenum hydroxylase superfamily and consists of two identical
subunits of 145 kDa. Each subunit of the molecule is composed of
an N-terminal 20-kDa domain containing two iron-sulfur clusters,
a central 40-kDa FAD-binding domain and a C-terminal 85-kDa
molybdopterin-binding domain with the four redox centers
aligned in an almost linear fashion. Its active form is a homodimer
of 290 kDa with each of the monomers acting independently in
catalysis [1]. XO is a cytosolic enzyme present in various species,
namely bacteria, higher plants, invertebrates and vertebrates [2].
It is also present in several mammalian tissues such as liver,
intestine, kidney, lungs, myocardium, brain, plasma and erythro-
cytes. Among them, XO activity is highest in liver and intestine
[3].
XO is the enzyme, which participates in purine degradation, is
the main contributor of free radicals during exercise [4,5]. It uses
molecular oxygen as the electron acceptor thereby resulting in
production of superoxide radical (O2
N2) and hydrogen peroxide
(H2O2) [4]. However, XO also results in uric acid production
which constitutes the most abundant antioxidant molecule in
plasma. Thus, the role of XO in redox status is unequivocal since
its activity leads to the production of both free radicals and uric
acid. Furthermore, XO exhibits a broad specificity toward
oxidation of a wide variety of heterocyclic compounds such as
purines and pteridines [6,7] and numerous aliphatic and aromatic
aldehydes to the corresponding carboxylic acid [8,9]. Therefore, it
participates in the detoxification of endogenous compounds and
xenobiotics.
XO is considered as a major contributor of free radicals in
various pathological conditions. More specifically, XO has been
implicated in several diseases including ischemia-reperfusion
injury, myocardial infarction, hypertension, atherosclerosis, dia-
betes and cancer [1]. As it has been previously stated XO results
not only in free radical production but also in uric acid generation.
Gout is a condition where excessive uric acid formation leads to its
crystallization and deposition of uric acid crystals in the joints, the
connective tissues and the kidneys [10]. Thus, the inhibition of
XO activity may have simultaneously antiradical and inhibitory
properties with therapeutic interest. The most commonly used and
well studied XO inhibitor is allopurinol [11,12].
Allopurinol [4-hydroxypyrazolo (3,4-d) pyrimidine] is a struc-
tural analogue of hypoxanthine [13]. It inhibits the conversion of
hypoxanthine to xanthine to uric acid thus decreasing uric acid
concentration. It is the only specific competitive, non natural XO
inhibitor and is widely used as a drug. Moreover, due to its
property to inhibit O2
N2 production, via XO inhibition,
allopurinol is considered as a potent antioxidant [5]. However,
this is controversial because allopurinol is also considered as a
prooxidant molecule because it leads to inhibition of uric acid
production as well [14].
Recently, a lot of research has been conducted in order to
discover new, natural and specific XO inhibitors [1]. Various
plant extracts [15,16] and polyphenolic compounds, especially
flavonoids [17,18], have been previously examined for their
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important source of polyphenols including flavonoids (kaempferol,
quercetin, anthocyanins and tannins), flavonoid glycosides,
isoflavones, phenolic acids and lignans [19,20].
In a previous study in our research group, several extracts
derived from Leguminosae family plants cultivated in Greece have
been studied for their antioxidant and chemopreventive properties
[21]. More specifically, Leguminosae family plant extracts and 14
fractions rich in polyphenolic compounds isolated from 2 of them
exhibited potent antiradical and chemopreventive properties and
protected DNA against free radical-induced damage [21,22]. In
extending these studies, we examined the effects of some of the
aforementioned extracts on XO activity. From the results
obtained, the extracts exhibited potent inhibitory activity on XO
implying that polyphenols present in them are responsible for their
biological properties [23]. Our previous results imply that these
specific plant extracts are a possible source of new natural XO
inhibitors. Thus, in the present study we examined the inhibitory
activity of the 14 fractions and pure polyphenolic compounds
isolated from them on XO.
Materials and Methods
There were no specific permits were required for the described
field studies. In addition, no specific permissions were required for
the collection of the plants, where the extracts were obtained. This
is because the studied legume plants are very common in Greece
and they are not cultivated in privately-owned or protected areas.
Finally, the field studies did not involve endangered or protected
species.
Chemicals and reagents
Xanthine oxidase from bovine milk and allopurinol were
purchased from Sigma-Aldrich (St Louis MO, USA). All the
other chemicals, KH2PO4,N a 2HPO42H2O and EDTA, were
purchased from Sigma-Aldrich (St Louis MO, USA) and were of
the highest quality ($99.0%) commercially available.
Plant material
The edible plants V. faba and L. edulis (Leguminosae) were
cultivated in a parcel near to village ‘Zaros’ of the island Crete
(Greece). After harvesting (2005), the aerial parts of the plants
(leaves and branches) were transferred to the laboratory and left to
dry under shadow at room temperature. The air-dried aerial plant
parts were pulverized by a mill machine (Allenwest, Brighton,
England).
Extraction, fractionation and identification of
polyphenolic isolates
The extraction, fractionation and identification of the polyphe-
nolic fractions has been previously described [21]. Thin-layer
chromatography (TLC) was carried out on glass pre-coated silica
gel 60 F254 plates (Merck). Fast centrifugal partition chromatog-
raphy (FCPC) was performed using a CPC KROMATON with a
1000 mL column, adjustable rotation of 200–2000 rpm and a Lab
Alliance pump with a pressure safety limit of 50 bars. A manual
sample injection valve was used to introduce the samples into the
column. A Thermo Finnigan HPLC instrument was employed
making use of a SpectraSystem P4000 pump, SpectraSystem 1000
degasser, SpectraSystem AS3000 automated injector and a UV
SpectralSystem UV2000 detector. NMR spectra were obtained
with a Bruker AC200 (200 MHz) and a Bruker DRX 400
(400 MHz) spectrometer. Chemical shifts were given as d values
with TMS as the internal standard. The 2-D experiments (COSY,
COSY LR, HMQC, HMBC, TOCSY and NOESY) were
performed using standard Brucker micro programs. ESMS
(Electron Spray Mass Spectrometry) were recorded with a Nermag R
10 10 C apparatus.
In details, the powder of the aerial parts of V. faba (0.890 Kg)
and L. edulis (0.490 Kg) were extracted with CH2Cl2 (dichloro-
methane), MeOH (methanol) and H2O (water), successively. Each
solvent extraction (365 L) was repeated three times, for 48 h per
extraction. The MeOH extract of V. faba (48.1 g) was processed
with resin XAD-4 in purpose to separate the total of phenolic
compounds (12.4 g). A part of this fraction (12 g) was subjected to
CPC separation using a mixture of EtOAc: n-BuOH: H2O (2:1:3)
as biphasic system. The separation was run at a revolution speed of
1000 rpm. Initially, the lower phase was used as the mobile phase
(water based), while the upper phase was used as the stationary
phase in a head to tail or descending mode (flow rate 15 mL/min).
The effluent of the column was manually collected in 30 mL
aliquots and this procedure resulted in eleven fractions (Vf A–L).
Then, the organic layer in a tail to head or ascending mode and
five fractions (Vf M–Q) were collected.
Similarly, a part of the L. edulis MeOH extract (12 g) was
subjected to CPC separation using a mixture of heptane: EtOAc:
MeOH: H2O (1:4:1:4) as biphasic system. The separation was run
at a revolution speed of 1100 rpm. Initially, the upper layer of the
biphasic system was used as the mobile phase, while the lower
layer (water based) was used as the stationary phase in a tail to
head or ascending mode (flow rate 15 mL/min). The effluent of
the column was manually collected in 30 mL aliquots and this
procedure resulted in nine fractions (Le A–I). Then, the water
layer was used as mobile phase in a head to tail or descending
mode and six fractions (Le K–P) were collected.
All fractions isolated from both plants, were examined by thin
layer chromatography (TLC) and analytical high performance
liquid chromatography (HPLC) using a 25064.0 mm i.d Lichro-
sorb RP18 column (BIRSHOFF Chromatography, Loenberg,
Germany). The mobile phase was a linear gradient of 2% aqueous
acetic acid (solvent A) and acetonitrile (solvent B). Conditions:
initial A–B (95:5); in 70 min A–B (75:25); back to initial
conditions; flow rate 1 mL/min. Further purification of com-
pounds of interest was accomplished using preparative HPLC. All
compounds were structurally elucidated using 1D and 2D NMR
spectroscopy as well as UV and MS techniques (Fig. 1). All the
known compounds (1–11) were confirmed by comparison to
literature data [24–39]. Compounds 12 and 13 were new and
their characterization was described in a previous study of ours
[21].
Fractions and pure polyphenolic compounds
Ten fractions were isolated from the aerial parts extract of V.
faba and four from the extract of L. edulis (Table 1). Fourteen
polyphenolic compounds were identified in the fractions and apart
from compound 3 they are kaempferol and quercetin glycosides.
The structure of the compounds that constitute each fraction is
depicted in Fig. 1 and classified according to the basic flavonoid
structure. More specifically the compounds identified are:
Compound 1: Quercetin 3-O-[a-L-rhamnopyranosyl(1R2)-b-D-
galactopyranosyl]-7-O-a-L-rhamnopyranoside; Compound 2:
Quercetin 3-O[a-L-rhamnopyranosyl(1R2)-b-D-glucopyranosyl]-
7-O-a-L-rhamnopyranoside; Compound 3: (6S,9R)-Roseoside;
Compound 4 (a,b isomers): Kaempferol 3-O-[a-L-rhamnopyr-
anosyl(1R2)-b-D-glucopyranosyl]-7-O-a-L-rhamnopyranoside and
Kaempferol 3-O-[a-L-rhamnopyranosyl(1R2)-b-D-galactopyrano-
syl]-7-O-a-L-rhamnopyranoside; Compound 5: 5: Kaempferol 3-O-
b-D-galactopyranosyl-7-O-a-L-rhamnopyranoside; Compound 6:
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pyranosyl]-7-O-a-L-rhamnopyranoside; Compound 7: Kaempferol
3-O-a-L-rhamnopyranosyl-7-O-a-L-rhamnopyranoside; Compound
8: Kaempferol 3-O-(6-O-b-D-acetylglucopyranosyl)-7-O-a-L-rham-
nopyranoside; Compound 9: Kaempferol 3-O-a-L-arabinopyrano-
syl-7-O-a-L-rhamnopyranoside; Compound 10: Kaempferol 3-O-b-
D-glucopyranosyl-7-O-a-L-rhamnopyranoside; Compound 11a:
Kaempferol 3-O-(3-O-acetyl-a-L-rhamnopyranosyl)-7-O-a-L-rham-
Figure 1. Chemical structures of the polyphenolic compounds isolated from the legume plant extracts.
doi:10.1371/journal.pone.0032214.g001
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rhamnopyranosyl)-7-O-a-L-rhamnopyranoside; Compound 12:
Kaempferol 3-O-b-D-apiofuranosyl-7-O-a-L-rhamnopyranoside;
Compound 13: Kaempferol 3-O-(5-O-acetyl-b-D-apiofuranosyl)-7-
O-a-L-rhamnopyranoside.
The composition of the fractions with the aforementioned
compounds is presented in Table 1. Only fraction Vf L is consisted
of unidentified non polar compounds. On the contrary with V. faba
fractions, which were consisted of a combination of phenolic
compounds, L. edulis fractions were mainly consisted of pure
flavonoid compounds (Table 1). Only Le E fraction was consisted
of a mixture of two isomers of compound 11, 11a and 11b
(Table 1).
Assessment of XO activity
XO activity was determined by measuring the formation of uric
acid from xanthine within a set time. Changes in the levels of uric
acid produced through the presence of the test samples allow the
potency of inhibitors to be assessed. Initially the effect of the
polyphenolic fractions and compounds on the inhibition of
enzymatic activity was assessed at substrate concentration where
maximum velocity was obtained. All initial reaction rates were in
the linear scale and were measured over the first 4 min of the
reaction. Each assay was performed in triplicates and the
optical density was measured using a Hitachi U-1500 Spectro-
photometer (San Jose, USA). The reaction mixture (500 mL)
contained sodium phosphate buffer (33 mM pH 7.5 with EDTA
0.1 mM), xanthine (4.8 mM) and the extract in various con-
centrations. The reaction was initiated through the addition of
43 mU unit of XO diluted in H2O. The production of uric acid
was determined at room temperature at 295 nm for 4 min.
Control samples were prepared identically to the test samples
without the addition of the specimen.
The IC50 values were determined as the concentration of the
fractions or compounds required to inhibit XO activity by 50%
monitoredthroughthedecreaseinuricacid production.Allopurinol
was used as positive control since it is a known inhibitor of XO [12].
The measured absorbance was corrected for the contribution of the
tested fractions and the pure polyphenolic compounds.
Statistical analysis
Statistical computations were carried out using SPSS 13.0
software. For statistical analysis, one-way ANOVA was applied
followed by Dunnett’s test for multiple pair-wise comparisons.
Differences were considered significant at p,0.05. The steady state
kinetic parameters (Km and Vmax) were determined (under standard
assays conditions) by analyzing formationof uric acid from xanthine
under initial rate conditions using the Lineweaver-Burk lineariza-
tion of the Micaelis-Menten equation. The Ki values and the
apparent kinetic parameters Km and Vmax were analyzed with the
statistic package Grafit 6 (Erithacus Software, Ltd., Horley, UK).
Results
Inhibitory activity of the polyphenolic fractions
All the fractions isolated form both V. faba and L. edulis plant
extracts were potent inhibitors of XO. IC50 values range from 40–
135 mg/mL and 55–260 mg/mL for V. faba and L. edulis fractions,
respectively (Table 1). All the polyphenolic fractions showed
higher XO inhibition than that of the initial plant extracts
(Table 1). According to the results of V. faba fractions, Vf N exerted
the most potent inhibitory activity on XO whereas Vf B was the
less potent. Regarding L. edulis, Le E and Le N were the most and
the less potent fractions, respectively.
Inhibitory activity of the pure polyphenolic compounds
From the 14 identified compounds only 11 were tested for their
inhibitory activity on XO (Table 2). More specifically, the
compounds 6 and 8 were not isolated because they were detected
in very low quantities in the fractions (Fig. 1). Additionally, the
compounds 11a and 11b could not be separated from the fraction
Le E (Table 1, Fig. 1).
All the pure polyphenolic compounds inhibited XO (Table 2).
The Ki values range from 13–767 mM. According to the kinetic
analysis compound 13 was the only competitive and the most
potent inhibitor (Fig. 2). The remaining 10 compounds followed
the non competitive inhibitory model (Table 2). Compound 4b
was the most potent among them (Table 2) and compound 3 the
less potent. Additionally, all the compounds were less potent
inhibitors than allopurinol (Table 2).
Discussion
Legumes have recently gained a lot of interest for the beneficial
health implications of their polyphenolic compounds [19,20].
Dietary polyphenolic compounds, especially flavonoids, except
their potent antioxidant activity [39,40] they are potent inhibi-
tors of XO activity [17,18]. XO is the main contributor of free
radicals during exercise but it is also involved in pathogenesis of
several diseases such as vascular disorders, cancer and gout
[1,5,10]. In order to discover new natural, dietary XO inhibitors,
some polyphenolic fractions and pure compounds isolated from
two legume plant extracts were tested for their effects on XO
activity.
Table 1. IC50 values and composition of the polyphenolic
fractions isolated from the methanolic extracts of aerial plant
parts of V. faba and L. edulis.
Fractions from
V. faba extract
IC50
(mg/mL) Compounds
Compounds
ratio
Vf N 40 7:8 2:1
Vf P 55 9:10 1:1
Vf E 66 3:4 3:1
Vf I 72 5:6 1:4
Vf K 72 5:10:6 4:1:2
Vf C 85 1:2 2:1
Vf L 94 mixture of non polar compounds
Vf Q 95 5:10 2:3
Vf F 115 3:4 2:1
Vf B 135 1:2:3 3:1:3
Meth. V. faba extract 540
Fractions from
L. edulis extract
IC50
(mg/mL) Compounds
Compounds
ratio
Le E 55 11 a,b (isomers) 1:1
Le O 90 12 1
Le B 97 13 1
Le N 260 7 1
Meth. L. edulis extract 410
doi:10.1371/journal.pone.0032214.t001
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polyphenolic compounds are originated from, exhibited potent XO
inhibitory activity (Table 1). From the results obtained, all the
polyphenolic fractions were more potent than the initial total
extracts. The different combinations of polyphenolic compounds
present in each fraction could partly explain the different inhibitory
efficiency of the fractions (Table 1). The most potent activity of the
isolates also implies that the polyphenolic compounds may act
differently when they are present in an extract. For example, Vf N
which was the most potent polyphenolic fraction had IC50 value at
40 mg/mL,whereastheinitialV.faba plantextract had IC50valueat
540 mg/mL. Additionally, their enrichment in the procedure of
their final preparation may be another reason for their high activity
as compared to their initial fractions.
All the pure polyphenolic compounds inhibited XO and the Ki
values range from 13 to767 mM (Table 2). Their IC50 values,
range from 42 to 260 mg/mL implying that the pure compounds
exert the same pattern of action either they are pure or as a
mixture in a fraction (Table 1). A representative example is the
fraction Vf P which is consisted of the compounds 9 and 10 in the
same ratio (1:1). The IC50 values of the compounds 9 and 10 are
63 and 42 mg/mL respectively whereas the IC50 of the Vf P
fraction is 55 mg/mL, demonstrating that there is not a synergistic
effect of the two compounds.
It is noteworthy that all potent compounds were flavonol
glycosides and more specifically kaempferol and quercetin
glycosides. Various flavonoids are known for their inhibitory
activity on XO. Regarding the basic chemical structure of
flavonols, the hydroxyl groups at C5 and C7 along with the
double bond between C2 and C3 were found to be essential for
their high inhibitory activity [17,41]. The compounds tested in the
present study have the double bond between C2 and C3 and the
unsubstituted hydroxyl group at C5, whereas the hydroxyl groups
at C7 and C3 are substituted with the glycosides (Fig. 1).
Consequently, the observed inhibitory activity is partly attributed
to these characteristics. However, quercetin and kaempferol, the
aglycone forms of our compounds, exhibit very low Ki values in
comparison with our results [18]. Previous studies have demon-
strated that the substitution of hydroxyl groups at C7 and C3 of
the basic flavonoid structure by a glycoside or a methyl group
seems to decrease the XO inhibitory effect [41]. Therefore, the
presence of the glycosides is responsible for the lower inhibitory
activity of our compounds.
According to the kinetic analysis, compound 13 was the only
competitive and the most potent inhibitor (Fig. 2). The compound
3 which is a non flavonoid had the less potent inhibitory activity
(Fig. 1). It is noteworthy that compound 13 differs from compound
12 in one acetyl group (-COCH3) at its chemical structure.
Unexpectedly such a small structural difference may result in the
different competition scheme (Table 2) (Fig. 1,2). Similarly, these
compounds exhibited different antioxidant and chemopreventive
properties (21). Additionally, it is noteworthy despite the fact that
compounds 4a and 4b constitute isomers of the same compound
they exhibited different potency at their inhibitory action (Table 2).
It seems that the inhibitory activity of the compounds depends on
the position of the hydroxyl group (4a equatorial, 4b axial) at the
glycoside substituting the hydroxyl group C3 of the basic flavonoid
structure (Fig. 1). Furthermore, compounds 1, 2, 9 and 10 were
potent non competitive inhibitors. Despite the fact that quercetin
glycosides 1 and 2 and kaempferol glycosides 9 and 10 have
structure differences in their C3-O-glycoside, they exert similar
activities (Table 2, Fig. 1).
In order to elucidate the specific mechanism of inhibition and
justify the aforementioned differences, more detailed kinetic analysis
and structural work is in progress in order to find the mode of
binding of these compounds to the enzyme molecule, since the
crystal structure of XO from bovine milk has been previously
elucidated [42,43]. As yet, reports concerning the mode of inhibition
of polyphenolic compounds have been contradictory [41].
As mentioned above, allopurinol was used as a positive marker of
potent XO inhibitory activity. Indeed, its Ki value was about 10 to
1000 fold lower than the Ki values of the tested polyphenolic
compounds (Table 2). This is due to the fact that allopurinol is a
structural isomer of xanthine and a specific competitive inhibitor of
XO. The polyphenolic compounds tested are novel, natural XO
inhibitors. However the findings of this study serve as preliminary
data for further modifications in the structure of the compounds.
When the mechanism of XO inhibition is fully explained, there is
possibility that some of these molecules may serve as lead
compounds with better and more specific inhibitory properties for
drug design. These molecules arenatural products that possibly lack
the side effects of allopurinol [11].
The pleiotropic action of the polyphenolic fractions isolated from
the legume extracts have been previously investigated and assessed
[21]. More specifically, they possess potent antioxidant and
chemopreventive properties against free radical-induced
DNA damage [21]. Generally, polyphenols have been estab-
lished as pleiotropic molecules with various biological properties
[44]. Furthermore, XO inhibition is mainly considered as a
mechanism of the antioxidant activity of polyphenols as the
majority of the studies consider XO as a contributor of free radicals
[41,45]. Thus, these flavonoid isolates and the initial extracts and
fractions may be used as antioxidant, nutritional supplements.
Antioxidants and polyphenolic compounds have been widely
used as part of human daily diet or as supplements especially
before exercise in order to provide protection against exercise-
induced oxidative stress or tissue oxidative damage. However, XO
inhibition leads not only to decrease of free radical production but
also to inhibition of uric acid generation. When oxidative stress is
present, uric acid is necessary as potent antioxidant molecule. It is
not well established if inhibition of free radical production or uric
acid generation is more useful during exercise. Recent evidence of
our research group have demonstrated that allopurinol adminis-
tration, a known antioxidant molecule and XO inhibitor, induced
oxidative stress and reduced performance after swimming until
Table 2. Inhibition type and Ki values of the pure
compounds.
Pure compounds Ki (mM) Inhibition type
Allopurinol 0.55 Competitive
1 115 Non competitive
2 186 Non competitive
3 767 Non competitive
4a 651 Non competitive
4b 50 Non competitive
5 345 Non competitive
7 296 Non competitive
9 210 Non competitive
10 177 Non competitive
12 215 Non competitive
13 13 Competitive
doi:10.1371/journal.pone.0032214.t002
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for ameliorating the harmful effects of exercise.
The findings of this study indicate that flavonoid isolates from
fractions derived from legume plant extracts are novel, natural
XO inhibitors. Their mode of action is under investigation in
order examine their potential in drug design for XO related
diseases such as gout. Considering that legumes have beneficial
health implications, they may be used as dietary supplements.
Nevertheless, regarding that XO inhibition seems to favour
oxidative stress their supplementation before exercise should be
carefully considered.
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